{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:02:56Z","timestamp":1794492176165,"version":"4.9.1"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Anaphylaxis is common in old-age adults but is insufficiently understood by physicians, and may be underdiagnosed. This review discusses the specificities of anaphylaxis in this age group and stresses the importance of adrenaline in its management.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Data from the European Anaphylaxis Registry on elderly patients is a major finding. Other findings include the prevention of possible anaphylactic reactions in coronavirus disease 2019 vaccination as well as some new epidemiologic data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>The most common risk factors are hymenoptera venom and food and drug allergy. Cardiovascular symptoms are the most important ones to reverse in old-age adults, especially due to the multiple comorbidities. Anaphylaxis in old-age adults has a more severe outcome than in younger ones. Polypharmacy is a specific factor to be considered. The Airway, Breathing, Circulation, Disability, Exposure (ABCDE) algorithm is applicable in all clinical emergencies for immediate assessment and treatment, and should be considered for all patients. Adrenaline is the mainstay of the management of the condition. There are no absolute contraindications to the prescription of self-injectable adrenaline in elderly individuals at risk of anaphylaxis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aci.0000000000000855","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T12:18:22Z","timestamp":1664281102000},"page":"435-440","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Anaphylaxis in elderly people"],"prefix":"10.1097","volume":"22","author":[{"given":"Maria Teresa","family":"Ventura","sequence":"first","affiliation":[{"name":"Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Boni","sequence":"additional","affiliation":[{"name":"Allergologia e Autoimmunit\u00e0 LUM, Maggiore Hospital, AUSL Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Taborda-Barata","sequence":"additional","affiliation":[{"name":"UBIAir \u2013 Clinical & Experimental Lung Centre, University of Beira Interior, Covilh\u00e3 and CICS-Health Sciences Research Centre, University of Beira Interior, Covilh\u00e3, Portugal"},{"name":"Department of Immunoallergology, Cova da Beira University Hospital Centre, Covilh\u00e3, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Blain","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Montpellier University Hospital, MUSE, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bousquet","sequence":"additional","affiliation":[{"name":"Institute of Allergology, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany"},{"name":"University Hospital Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,9,14]]},"reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000355307","article-title":"Allergic disorders at a venerable age: a mini-review","volume":"60","author":"Milgrom","year":"2014","journal-title":"Gerontol"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1586\/1744666X.2015.1081564","article-title":"Management of allergic disease in the elderly: key considerations, recommendations and emerging therapies","volume":"11","author":"Ventura","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jaip.2017.06.028","article-title":"Anaphylaxis: recognizing risk and targeting treatment","volume":"5","author":"Golden","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3389\/fimmu.2019.00750","article-title":"Anaphylaxis in elderly patients\u2014data from the European Anaphylaxis Registry","volume":"10","author":"Aurich","year":"2019","journal-title":"Front Immunol"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jaci.2013.10.029","article-title":"Case fatality and population mortality associated with anaphylaxis in the United States","volume":"133","author":"Ma","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1111\/all.14838","article-title":"Management of anaphylaxis due to COVID-19 vaccines in the elderly","volume":"76","author":"Bousquet","year":"2021","journal-title":"Allergy"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"956.e1","DOI":"10.1016\/j.jaci.2014.10.021","article-title":"Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data","volume":"135","author":"Turner","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"2831.e8","DOI":"10.1016\/j.jaip.2021.03.032","article-title":"Trends in emergency department visits and hospitalizations for acute allergic reactions and anaphylaxis among US older adults: 2006\u20132014","volume":"9","author":"Arroyo","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/all.13380","article-title":"Factors increasing the risk for a severe reaction in anaphylaxis: an analysis of data from the European Anaphylaxis Registry","volume":"73","author":"Worm","year":"2018","journal-title":"Allergy"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"1448.e1","DOI":"10.1016\/j.jaci.2019.07.037","article-title":"Detection of KIT D816\u200aV mutation in patients with severe anaphylaxis and normal basal tryptase-first data from the Anaphylaxis Registry (NORA)","volume":"144","author":"Dolle-Bierke","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","article-title":"Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity","volume":"124","author":"Rueff","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"698.e1","DOI":"10.1016\/j.jaci.2012.03.024","article-title":"Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria\/angioedema","volume":"130","author":"Stoevesandt","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1111\/all.14785","article-title":"beta-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy","volume":"76","author":"Sturm","year":"2021","journal-title":"Allergy"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/cea.12276","article-title":"Angiotensin-converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build-up phase","volume":"44","author":"Stoevesandt","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12948-017-0059-2","article-title":"Allergic diseases in the elderly: biological characteristics and main immunological and nonimmunological mechanisms","volume":"15","author":"Ventura","year":"2017","journal-title":"Clin Mol Allergy"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"63.e3","DOI":"10.1016\/j.anai.2022.03.020","article-title":"Anaphylaxis among elderly emergency department patients in a large health system in New York","volume":"129","author":"Meir","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jaip.2015.12.019","article-title":"Safety, costs, and efficacy of rapid drug desensitizations to chemotherapy and monoclonal antibodies","volume":"4","author":"Sloane","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"159.e2","DOI":"10.1016\/j.jaci.2018.02.018","article-title":"Hypersensitivity reactions to therapeutic monoclonal antibodies: phenotypes and endotypes","volume":"142","author":"Isabwe","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.anai.2011.01.011","article-title":"Anaphylaxis in emergency department patients 50 or 65\u200ayears or older","volume":"106","author":"Campbell","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa2028436","article-title":"Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults","volume":"383","author":"Anderson","year":"2020","journal-title":"N Engl J Med"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaci.2013.01.011","article-title":"Antihypertensive medication use is associated with increased organ system involvement and hospitalization in emergency department patients with anaphylaxis","volume":"131","author":"Lee","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0140-6736(77)91953-5","article-title":"Incidence and severity of anaphylactoid reactions to colloid volume substitutes","volume":"1","author":"Ring","year":"1977","journal-title":"Lancet"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/all.12765","article-title":"Time for a new grading system for allergic reactions?","volume":"71","author":"Niggemann","year":"2016","journal-title":"Allergy"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/all.13408","article-title":"The urgent need for a harmonized severity scoring system for acute allergic reactions","volume":"73","author":"Muraro","year":"2018","journal-title":"Allergy"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"Ruggeberg","year":"2007","journal-title":"Vaccine"},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(07)61092-7","article-title":"The challenge of managing drug interactions in elderly people","volume":"370","author":"Mallet","year":"2007","journal-title":"Lancet"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"1318.e7","DOI":"10.1016\/j.jaci.2014.08.018","article-title":"Fatal anaphylaxis in the United States, 1999\u20132010: temporal patterns and demographic associations","volume":"134","author":"Jerschow","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy"},{"key":"R29-20250527","first-page":"4-1","article-title":"Anaphylaxis","volume":"53","author":"Bilo","year":"2021","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"R30-20250527","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/ACI.0000000000000071","article-title":"Anaphylaxis and cardiovascular diseases: a dangerous liaison","volume":"14","author":"Triggiani","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"(Suppl 1)","key":"R31-20250527","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2249.2008.03714.x","article-title":"Allergy and the cardiovascular system","volume":"153","author":"Triggiani","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"R32-20250527","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/cea.12520","article-title":"Anaphylaxis and cardiovascular disease: therapeutic dilemmas","volume":"45","author":"Lieberman","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"R33-20250527","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11882-021-01010-1","article-title":"Hereditary alpha-tryptasemia: a commonly inherited modifier of anaphylaxis","volume":"21","author":"Wu","year":"2021","journal-title":"Curr Allergy Asthma Rep"},{"key":"R34-20250527","doi-asserted-by":"crossref","first-page":"1141.e5","DOI":"10.1016\/j.jaci.2013.06.015","article-title":"Anaphylaxis: clinical patterns, mediator release, and severity","volume":"132","author":"Brown","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"R35-20250527","doi-asserted-by":"crossref","first-page":"879.e5","DOI":"10.1016\/j.jaip.2018.10.042","article-title":"Relationship between anaphylaxis and use of beta-blockers and angiotensin-converting enzyme inhibitors: a systematic review and meta-analysis of observational studies","volume":"7","author":"Tejedor-Alonso","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"(Suppl)","key":"R36-20250527","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.amjmed.2013.09.008","article-title":"Recognition and first-line treatment of anaphylaxis","volume":"127","author":"Lieberman","year":"2014","journal-title":"Am J Med"},{"key":"R37-20250527","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/IJGM.S28478","article-title":"Initial assessment and treatment with the Airway, Breathing, Circulation, Disability, Exposure (ABCDE) approach","volume":"5","author":"Thim","year":"2012","journal-title":"Int J Gen Med"},{"key":"R38-20250527","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/all.12437","article-title":"Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology","volume":"69","author":"Muraro","year":"2014","journal-title":"Allergy"},{"key":"R39-20250527","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40413-015-0080-1","article-title":"2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines","volume":"8","author":"Simons","year":"2015","journal-title":"World Allergy Organ J"},{"key":"R40-20250527","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12948-018-0083-x","article-title":"Importance of hypersensitivity in adverse reactions to drugs in the elderly","volume":"16","author":"Ventura","year":"2018","journal-title":"Clin Mol Allergy"},{"key":"R41-20250527","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/ACI.0b013e32833bc670","article-title":"Epinephrine and its use in anaphylaxis: current issues","volume":"10","author":"Simons","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R42-20250527","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaip.2014.06.007","article-title":"Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine","volume":"3","author":"Campbell","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R43-20250527","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/all.12908","article-title":"Self-medication of anaphylactic reactions due to Hymenoptera stings\u2014an EAACI Task Force Consensus Statement","volume":"71","author":"Bilo","year":"2016","journal-title":"Allergy"},{"key":"R44-20250527","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1016\/j.jaip.2019.04.040","article-title":"Age-related cardiovascular outcomes in older adults receiving epinephrine for anaphylaxis in the emergency department","volume":"7","author":"O\u2019Brien","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R45-20250527","doi-asserted-by":"crossref","first-page":"e755","DOI":"10.1097\/MJT.0000000000000910","article-title":"Glucagon for refractory anaphylaxis","volume":"26","author":"Rukma","year":"2019","journal-title":"Am J Ther"},{"key":"R46-20250527","article-title":"A Rapid review of advanced life support guidelines for cardiac arrest associated with anaphylaxis","author":"McLure","year":"2020","journal-title":"Resuscitation"}],"container-title":["Current Opinion in Allergy &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACI.0000000000000855","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T18:10:23Z","timestamp":1748369423000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ACI.0000000000000855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0000000000000855","relation":{},"ISSN":["1528-4050","1473-6322"],"issn-type":[{"value":"1528-4050","type":"print"},{"value":"1473-6322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,14]]}}}